Healthcare provider profile · identity verified

Anthony Lesch, PA-C

Physician Assistant · BUFFALO, MN · NPI 1306864368

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	224	72
Levothyroxine Sodium	Levothyroxine Sodium	166	43
Lisinopril	Lisinopril	160	50
Amlodipine Besylate	Amlodipine Besylate	154	46
Omeprazole	Omeprazole	145	41
Metoprolol Succinate	Metoprolol Succinate	141	42
Tamsulosin Hcl	Tamsulosin Hcl	123	47
Simvastatin	Simvastatin	118	35
Rosuvastatin Calcium	Rosuvastatin Calcium	107	35
Losartan Potassium	Losartan Potassium	98	33
Warfarin Sodium	Warfarin Sodium	75	30
Prednisone	Prednisone	72	45
Gabapentin	Gabapentin	70	32
Metformin Hcl	Metformin Hcl	62	21
Pantoprazole Sodium	Pantoprazole Sodium	55	15
Furosemide	Furosemide	54	18
Pravastatin Sodium	Pravastatin Sodium	48	19
Duloxetine Hcl	Duloxetine Hcl	47	11
Metoprolol Tartrate	Metoprolol Tartrate	47	13
Hydrochlorothiazide	Hydrochlorothiazide	44	18
Jardiance	Empagliflozin	44	12
Meloxicam	Meloxicam	44	27
Eliquis	Apixaban	43	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	42	13
Famotidine	Famotidine	42	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	14
Fluticasone Propionate	Fluticasone Propionate	40	12
Metformin Hcl Er	Metformin Hcl	40	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	12
Trazodone Hcl	Trazodone Hcl	39	13
Doxycycline Hyclate	Doxycycline Hyclate	35	27
Potassium Chloride	Potassium Chloride	34	suppressed
Allopurinol	Allopurinol	33	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	suppressed
Bupropion Xl	Bupropion Hcl	31	12
Celecoxib	Celecoxib	31	13
Clonazepam	Clonazepam	31	suppressed
Alendronate Sodium	Alendronate Sodium	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Glimepiride	Glimepiride	30	11
Zolpidem Tartrate	Zolpidem Tartrate	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	14
Escitalopram Oxalate	Escitalopram Oxalate	26	suppressed
Torsemide	Torsemide	26	12
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Sertraline Hcl	Sertraline Hcl	23	suppressed
Atenolol	Atenolol	21	suppressed
Tramadol Hcl	Tramadol Hcl	21	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	20	17
Nystatin	Nystatin	18	suppressed
Azithromycin	Azithromycin	17	16
Ozempic	Semaglutide	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Alprazolam	Alprazolam	16	suppressed
Cefuroxime	Cefuroxime Axetil	16	15
Methocarbamol	Methocarbamol	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Amoxicillin	Amoxicillin	13	12
Fenofibrate	Fenofibrate	13	suppressed
Finasteride	Finasteride	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Carvedilol	Carvedilol	12	suppressed
Diazepam	Diazepam	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Cephalexin	Cephalexin	11	suppressed
Montelukast Sodium	Montelukast Sodium	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error